ETN vs SBUX: Which Is the Better Buy?

Side-by-side comparison of Eaton Corporation plc and Starbucks Corporation β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-08-06.
Eaton Corporation plc Β· Industrials
$447.28
-9.5% upside to fair value
Med Conviction Grade C+
VS
Starbucks Corporation Β· Consumer Cyclical
$100.65
-6.1% upside to fair value
Grade D
QuantHub Verdict
SBUX has more upside to fair value (-6.1%). ETN trades at a lower forward P/E (33.2x). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric ETN SBUX
Current Price $447.28 $100.65
Fair Value Estimate $405.00 $94.50
Upside to Fair Value -9.5% -6.1%
Market Cap $173.7B $114.7B
Forward P/E 33.2x 76.7x
EV / EBITDA 30.0x 25.6x
Price / Sales 5.8x 3.0x
Price / FCF 38.6x 42.1x
Revenue Growth YoY +21.0% +8.8%
Gross Margin 35.9% 20.4%
Operating Margin 17.7% 9.3%
Return on Equity 18.9% -18.3%
Dividend Yield 0.98% 0%
FCF Yield 2.59% 2.38%
Analyst Consensus Buy Hold
Investment Thesis
ETN β€” Eaton Corporation plc
Eaton is a 115-year-old power management company whose Electrical Americas, Electrical Global and Aerospace segments have become a core beneficiary of the same AI data-center, grid modernization and reshoring supercycle driving GE Vernova and Vertiv. Q2 2026 results were record-setting: revenue of $8.5 billion (up 21% year over year, 14% organic), adjusted EPS of $3.15, and segment margins of 23.…
SBUX β€” Starbucks Corporation
Starbucks Corporation operates a global coffeehouse chain with a strong brand and a leading digital/mobile platform, serving approximately 90 million customers weekly through over 28,000 stores in 77 countries. The company benefits from a durable competitive moat based on its extensive store footprint, brand recognition, and digital engagement rather than proprietary products. Despite solid reven…
Accumulation Zones
Metric ETN SBUX
Zone Low $305.00 $70.88
Zone High $345.00 $80.33
In Buy Zone? No No
← ETN Research    SBUX Research β†’    All Research